6678 Stock Overview
Engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Techno Medica Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,791.00 |
| 52 Week High | JP¥2,260.00 |
| 52 Week Low | JP¥1,550.00 |
| Beta | 0.11 |
| 1 Month Change | -1.59% |
| 3 Month Change | -10.14% |
| 1 Year Change | -20.04% |
| 3 Year Change | 6.10% |
| 5 Year Change | -14.22% |
| Change since IPO | 62.33% |
Recent News & Updates
Shareholder Returns
| 6678 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -0.6% | -1.4% | -1.5% |
| 1Y | -20.0% | 14.7% | 13.7% |
Return vs Industry: 6678 underperformed the JP Medical Equipment industry which returned 16.5% over the past year.
Return vs Market: 6678 underperformed the JP Market which returned 14.6% over the past year.
Price Volatility
| 6678 volatility | |
|---|---|
| 6678 Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 3.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 6678 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 6678's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 237 | Masatomo Saneyoshi | www.technomedica.co.jp |
Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID specimen management, inspection reception systems, reception and collation systems, automated urine aliquot and labeling systems, pre-analytical instruments, and blood and urine collection support, as well as blood gas, electrolytes, erythrocyte sedimentation rates, and ion selective electrode-certificated serums. It also provides consumables and after sales services.
Techno Medica Co., Ltd. Fundamentals Summary
| 6678 fundamental statistics | |
|---|---|
| Market cap | JP¥12.38b |
| Earnings (TTM) | JP¥1.19b |
| Revenue (TTM) | JP¥10.34b |
10.4x
P/E Ratio1.2x
P/S RatioIs 6678 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6678 income statement (TTM) | |
|---|---|
| Revenue | JP¥10.34b |
| Cost of Revenue | JP¥5.18b |
| Gross Profit | JP¥5.17b |
| Other Expenses | JP¥3.98b |
| Earnings | JP¥1.19b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | 172.59 |
| Gross Margin | 49.97% |
| Net Profit Margin | 11.53% |
| Debt/Equity Ratio | 0% |
How did 6678 perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yieldn/a
Payout RatioDoes 6678 pay a reliable dividends?
See 6678 dividend history and benchmarks| Techno Medica dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 97 days |
| Days until Dividend pay date | 188 days |
Does 6678 pay a reliable dividends?
See 6678 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 06:59 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Techno Medica Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuko Miyasako | Barclays |
| Yuta Kenmei | Marusan Securities Co. Ltd. |
| Hidekatsu Watanabe | Mizuho Securities Co., Ltd. |